Literature DB >> 28868576

Choice between delayed food and immediate opioids in rats: treatment effects and individual differences.

Leigh V Panlilio1,2, Maria E Secci3, Charles W Schindler3,4, Charles W Bradberry3.   

Abstract

RATIONALE: Addiction involves maladaptive choice behavior in which immediate drug effects are valued more than delayed nondrug rewards. OBJECTIVES AND METHODS: To model this behavior and extend our earlier work with the prescription opioid oxycodone, we allowed rats to choose between immediate intravenous delivery of the short-acting opioid remifentanil and delayed delivery of highly palatable food pellets. Treatment drugs were tested on a baseline where remifentanil was preferred over food.
RESULTS: Treatment with a high dose of the opioid antagonist naltrexone decreased but did not reverse the preference for remifentanil. Treatment with the serotonin 5-HT2C agonist lorcaserin decreased remifentanil and food self-administration nonselectively. Across conditions in which the alternative to delayed food was either a moderate dose of oxycodone, a moderate or high dose of remifentanil, a smaller more immediate delivery of food, or timeout with no primary reinforcement, choice was determined by both the length of the delay and the nature of the alternative option. Delayed food was discounted most steeply when the alternative was a high dose of remifentanil, which was preferred over food when food was delayed by 30 s or more. Within-subject comparisons showed no evidence for trait-like impulsivity or sensitivity to delay across these conditions.
CONCLUSIONS: Choice was determined more by the current contingencies of reinforcement than by innate individual differences. This finding suggests that people might develop steep delay-discounting functions because of the contingencies in their environment, and it supports the use of contingency management to enhance the relative value of delayed nondrug reinforcers.

Entities:  

Keywords:  Addiction; Concurrent choice; Delay discounting; Impulsivity; Intertemporal choice; Lorcaserin

Mesh:

Substances:

Year:  2017        PMID: 28868576      PMCID: PMC5664176          DOI: 10.1007/s00213-017-4726-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

Review 1.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

Review 2.  Serotonin and decision making processes.

Authors:  Judith R Homberg
Journal:  Neurosci Biobehav Rev       Date:  2011-06-12       Impact factor: 8.989

Review 3.  The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.

Authors:  Warren K Bickel; Mikhail N Koffarnus; Lara Moody; A George Wilson
Journal:  Neuropharmacology       Date:  2013-06-24       Impact factor: 5.250

4.  Impulsive choice predicts anxiety-like behavior, but not alcohol or sucrose consumption, in male Long-Evans rats.

Authors:  Jeffrey S Stein; C Renee Renda; Shayne M Barker; Kennan J Liston; Timothy A Shahan; Gregory J Madden
Journal:  Alcohol Clin Exp Res       Date:  2015-04-01       Impact factor: 3.455

5.  The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.

Authors:  Guy A Higgins; Leo B Silenieks; Anne Rossmann; Zoe Rizos; Kevin Noble; Ashlie D Soko; Paul J Fletcher
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

6.  The genetics of impulsivity: evidence for the heritability of delay discounting.

Authors:  Andrey P Anokhin; Julia D Grant; Richard C Mulligan; Andrew C Heath
Journal:  Biol Psychiatry       Date:  2014-11-07       Impact factor: 13.382

7.  Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys.

Authors:  Lisa R Gerak; Gregory T Collins; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2016-09-20       Impact factor: 4.030

8.  Delay discounting of food and remifentanil in rhesus monkeys.

Authors:  David R Maguire; Lisa R Gerak; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2013-05-02       Impact factor: 4.530

9.  A comparison of multiple 5-HT receptors in two tasks measuring impulsivity.

Authors:  John C Talpos; Lawrence S Wilkinson; Trevor W Robbins
Journal:  J Psychopharmacol       Date:  2005-10-04       Impact factor: 4.153

10.  Addiction and choice: theory and new data.

Authors:  Gene M Heyman
Journal:  Front Psychiatry       Date:  2013-05-06       Impact factor: 4.157

View more
  11 in total

1.  Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder.

Authors:  Laura Brandt; Jermaine D Jones; Suky Martinez; Jeanne M Manubay; Shanthi Mogali; Tatiana Ramey; Frances R Levin; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

2.  Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys.

Authors:  E Andrew Townsend; S Stevens Negus; Justin L Poklis; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2020-01-17       Impact factor: 4.492

3.  Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats.

Authors:  E Andrew Townsend; S Stevens Negus; S Barak Caine; Morgane Thomsen; Matthew L Banks
Journal:  Neuropsychopharmacology       Date:  2019-02-28       Impact factor: 7.853

4.  The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.

Authors:  Jimmie L Pirtle; Melissa D Hickman; Varun C Boinpelly; Kamalakar Surineni; Hemant K Thakur; Kenneth W Grasing
Journal:  Pharmacol Biochem Behav       Date:  2019-02-24       Impact factor: 3.533

5.  Heroin choice depends on income level and economy type.

Authors:  Tommy Gunawan; Yosuke Hachiga; Christopher S Tripoli; Alan Silberberg; David N Kearns
Journal:  Psychopharmacology (Berl)       Date:  2020-01-29       Impact factor: 4.530

6.  Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys.

Authors:  Lisa R Gerak; Charles P France
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.852

7.  Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys.

Authors:  Lisa R Gerak; Gregory T Collins; David R Maguire; Charles P France
Journal:  Exp Clin Psychopharmacol       Date:  2018-11-01       Impact factor: 3.157

Review 8.  Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Neuropsychopharmacology       Date:  2020-08-24       Impact factor: 7.853

9.  Remifentanil self-administration in mice promotes sex-specific prefrontal cortex dysfunction underlying deficits in cognitive flexibility.

Authors:  Eden M Anderson; Annabel Engelhardt; Skyler Demis; Elissa Porath; Matthew C Hearing
Journal:  Neuropsychopharmacology       Date:  2021-05-19       Impact factor: 8.294

Review 10.  Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders.

Authors:  Ken W Grasing; Kim Burnell; Alok De
Journal:  Behav Pharmacol       Date:  2022-03-23       Impact factor: 2.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.